Is three always greater than two?—azacitidine, venetoclax, and gilteritinib triple therapy in newly diagnosed and relapsed/refractory FLT3-mutant acute myeloid leukemia
@article{ACTR9960, author = {Matthew F. Jones and Catherine C. Smith}, title = {Is three always greater than two?—azacitidine, venetoclax, and gilteritinib triple therapy in newly diagnosed and relapsed/refractory FLT3-mutant acute myeloid leukemia}, journal = {AME Clinical Trials Review}, volume = {2}, number = {0}, year = {2024}, keywords = {}, abstract = {}, issn = {3005-6152}, url = {https://actr.amegroups.org/article/view/9960} }